Zacks Research Expects Reduced Earnings for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Equities research analysts at Zacks Research dropped their Q3 2025 EPS estimates for Henry Schein in a research report issued on Thursday, October 17th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $1.35 for the quarter, down from their previous forecast of $1.36. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein's FY2025 earnings at $5.19 EPS, Q3 2026 earnings at $1.39 EPS and FY2026 earnings at $5.67 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.10 billion during the quarter, compared to the consensus estimate of $3.27 billion. During the same period last year, the firm earned $1.31 EPS. The company's revenue for the quarter was up .0% on a year-over-year basis.

A number of other brokerages have also recently commented on HSIC. Baird R W raised shares of Henry Schein from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 22nd. Piper Sandler reiterated an "overweight" rating and issued a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. JPMorgan Chase & Co. cut their price objective on Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a research report on Monday, August 12th. Evercore ISI increased their target price on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. Finally, UBS Group cut their price target on Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $77.50.

Henry Schein Price Performance

Henry Schein stock traded up $0.72 during trading hours on Friday, hitting $72.39. The stock had a trading volume of 688,164 shares, compared to its average volume of 1,335,087. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63. The stock has a market capitalization of $9.27 billion, a price-to-earnings ratio of 24.26, a PEG ratio of 1.98 and a beta of 0.86. The stock's fifty day moving average is $70.33 and its two-hundred day moving average is $69.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.14% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Henry Schein

Hedge funds have recently made changes to their positions in the stock. Summit Securities Group LLC acquired a new position in Henry Schein in the second quarter valued at $31,000. Beach Investment Counsel Inc. PA acquired a new position in shares of Henry Schein in the 2nd quarter valued at about $37,000. Blue Trust Inc. grew its holdings in shares of Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock worth $60,000 after purchasing an additional 475 shares during the period. Mather Group LLC. grew its holdings in shares of Henry Schein by 16.8% during the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company's stock worth $96,000 after purchasing an additional 216 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its position in Henry Schein by 282.1% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company's stock worth $109,000 after purchasing an additional 1,100 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.